The impact of time-window bias on the assessment of the long-term effect of medication adherence: the case of secondary prevention after myocardial infarction

被引:17
|
作者
Di Martino, Mirko [1 ]
Kirchmayer, Ursula [1 ]
Agabiti, Nera [1 ]
Bauleo, Lisa [1 ]
Fusco, Danilo [1 ]
Perucci, Carlo Alberto
Davoli, Marina [1 ]
机构
[1] Lazio Reg Hlth Serv, Dept Epidemiol, Rome, Italy
来源
BMJ OPEN | 2015年 / 5卷 / 06期
关键词
MORTALITY;
D O I
10.1136/bmjopen-2015-007866
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: Time-window bias was described in case-control studies and led to a biased estimate of drug effect. No studies have measured the impact of this bias on the assessment of the effect of medication adherence on health outcomes. Our goals were to estimate the association between adherence to drug therapies after myocardial infarction (MI) and the incidence of a new MI, and to quantify the error that would have been produced by a time-window bias. Setting: This is a population-based study. Data were obtained from the Regional Health Information Systems of the Lazio Region in Central Italy (around 5 million inhabitants). Participants: Patients discharged after MI in 2006-2007 were enrolled in the cohort and followed through 2009. Outcome measure: The study outcome was reinfarction: either mortality, or hospital admission for MI, whichever occurred first. Design: A nested case-control study was performed. Controls were selected using both time-dependent and time-independent sampling. Adherence to antiplatelets, a-blockers, ACE inhibitors/angiotensin receptor blockers (ACEI/ARBs) and statins was calculated using the proportion of days covered (PDC). Results: A total of 6880 patients were enrolled in the cohort. Using time-dependent sampling, a protective effect was detected for all study drugs. Conversely, using time-independent sampling, the beneficial effect was attenuated, as in the case of antiplatelet agents and statins, or completely masked, as in the case of ACEI/ARBs and a-blockers. For ACEI/ARBs, the time-dependent approach produced ORs of 0.83 (95% CI 0.57 to 1.21) and 0.72 (0.55 to 0.95), respectively, for '0.5<PDC <= 0.75' and 'PDC>0.75' versus '0 <= PDC <= 0.5'. Using the time-independent approach, the ORs were 0.96 (0.65 to 1.43) and 1.00 (0.76 to 1.33), respectively. Conclusions: A time-independent definition of a time-dependent exposure introduces a bias when the length of follow-up varies with the outcome. The persistence of time-related biases in peer-reviewed papers strongly suggests the need for increased awareness of this methodological pitfall.
引用
收藏
页数:7
相关论文
共 50 条
  • [21] LONG TERM DUAL ANTIPLATELET THERAPY AFTER MYOCARDIAL INFARCTION IN CLINICAL PRACTICE: IMPACT OF NUISANCE BLEEDING ON MEDICATION ADHERENCE
    Ratti, G.
    Monda, C.
    Di Tommaso, C.
    Ratti, F.
    Fulgione, L.
    Fulgione, C.
    Mallardo, M.
    Tammaro, P.
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2022, 24 (SUPPL C)
  • [22] CONTROLLED TRIAL OF LONG-TERM HEPARIN ADMINISTRATION FOR PREVENTION OF SECONDARY MYOCARDIAL INFARCTION
    SCHETTLE.G
    SCHIMPF, K
    OBERHOFF.G
    CIRCULATION, 1969, 40 (4S3) : II22 - &
  • [23] Association of Diabetes Mellitus Status and Glycemic Control With Secondary Prevention Medication Adherence After Acute Myocardial Infarction
    Adamek, Kylie E.
    Ramadurai, Deepa
    Gunzburger, Elise
    Plomondon, Mary E.
    Ho, P. Michael
    Raghavan, Sridharan
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2019, 8 (03):
  • [24] Long-Term Effects of an Intensive Prevention Program After Acute Myocardial Infarction
    Osteresch, Rico
    Fach, Andreas
    Frielitz, Fabian-Simon
    Meyer, Sven
    Schmucker, Johannes
    Ruehle, Stephan
    Retzlaff, Tina
    Hadwiger, Moritz
    Haerle, Tobias
    Elsaesser, Albrecht
    Katalinic, Alexander
    Eitel, Ingo
    Hambrecht, Rainer
    Wienbergen, Harm
    AMERICAN JOURNAL OF CARDIOLOGY, 2021, 154 : 7 - 13
  • [25] Does adherence to medical therapy improve long-term survival after myocardial infarction?
    Jerry Avorn
    Nature Clinical Practice Cardiovascular Medicine, 2007, 4 : 354 - 355
  • [26] Does adherence to medical therapy improve long-term survival after myocardial infarction?
    Avorn, J.
    NATURE CLINICAL PRACTICE CARDIOVASCULAR MEDICINE, 2007, 4 (07): : 354 - 355
  • [27] Impact of diabetes on long-term mortality after presentation with acute myocardial infarction
    Gale, Chris P.
    Thow, Jonathan
    Batin, Phillip D.
    Hall, Alistair S.
    JOURNAL OF CARDIOVASCULAR MEDICINE, 2011, 12 (06) : 387 - 389
  • [28] Long-term impact of socioeconomic status after acute myocardial infarction in Korea
    Won, Hoyoun
    Kim, Yong-Hoon
    Kim, Jeongsook
    Kim, Yonghwan
    Kang, Hee-Taik
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2025, 35 (03)
  • [29] Effects of an intensive long-term prevention programme after myocardial infarction - a randomized trial
    Wienbergen, Harm
    Fach, Andreas
    Meyer, Sven
    Meyer, Jochen
    Stehmeier, Janina
    Backhaus, Tina
    Michel, Stephan
    Kraemer, Kirsten
    Osteresch, Rico
    Schmucker, Johannes
    Haase, Henning
    Haerle, Tobias
    Elsaesser, Albrecht
    Hambrecht, Rainer
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2019, 26 (05) : 522 - 530
  • [30] The secondary preventive heart school intervention and long-term outcome after myocardial infarction
    Wallert, J.
    Olsson, E.
    Norlund, F.
    Pingel, R.
    Leosdottir, M.
    Burell, G.
    Held, C.
    EUROPEAN HEART JOURNAL, 2018, 39 : 21 - 21